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Abstract
The stability constants of the mixed-ligand complexes formed between Cu(Arm)2+, where Arm 2,2’-
bipyridine (Bpy) or 1,10-phenanthroline (Phen), and the dianions of 9-[2-(phosphonomethoxy)ethyl]-8-aza-
adenine (9,8aPMEA) and 8-[2-(phosphonomethoxy)ethyl]-8-azaadenine (8,8aPMEA) (both also abbreviated
as PA2-) were determined by potentiometric pH titrations in aqueous solution (25 C; I 0.1 M, NaNO3). All
four ternary Cu(Arm)(PA) complexes are considerably more stable than corresponding Cu(Arm)(R-PO3)
species, where R-PO- represents a phosph(on)ate ligand with a group R that is unable to participate in any
kind of interaction within the complexes. The increased stability is attributed to intramolecular stack
formation in the Cu(Arm)(PA) complexes and also to the formation of 5-membered chelates involving the
ether oxygen present in the -CH2-O-CH2-POZ3 residue of the azaPMEAs. A quantitative analysis of the
intramolecular equilibria involving three structurally different Cu(Arm)(PA) species is carried out. For
example, about 5% of the Cu(Bpy)(8,8aPMEA) system exist with the metal ion solely coordinated to the
phosphonate group, 14% as a 5-membered chelate involving the -CH2-O-CH2-PO3 z- residue, and 81% with an
intramolecular stack between the 8-azapurine moiety and the aromatic rings of Bpy. The results for the other
systems are similar though with Phen a formation degree of about 90% for the intramolecular stack is
reached. The existence of the stacked species is also proven by spectrophotometric measurements. In
addition, the Cu(Arm)(PA) complexes may be protonated, leading to Cu(Arm)(H;PA)
+ species for which it is
concluded that the proton is located at the phosphonate group and that the complexes are mainly formed by a
stacking adduct between Cu(Arm)2+ and H(PA)-. Conclusions regarding the biological properties of these
azaPMEAs are shortly indicated.
1. INTRODUCTION
Nucleotides and their metal ion complexes play a key role in all aspects of metabolism and
therefore, attempts to exploit nucleotide analogues as drugs are old (e.g.[3l).4.Among the analogue,s
with biological properties 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA),t an analogue of (2-
deoxy)-adenosiae 5’-monophosohate [(d)AMp2-], is a most remarkable one; it exhibits antiviral,581
cytostatic[9,11 and antiarthritic[rl] effects.
Considering the broad biological activity of PMEA, it is not surprising that many derivatives
have been synthesized and studied,[2] and it is now clear that in order to be antivirally active,
PMEA and its derivatives must be phosphorylated in the cell to the diphosphate (PMEApp4-) and
this is then recognized by DNA polymerases as a substrate and incorporated into the growing
nucleic acid chain which is terminated thereafter.[3’4] Knowing that polymerases depend on the
presence of metal ions[15’16] and that the nucleoside 5’-triphosphates must be present as complexes
(mostly Mg2+)[7] we have been studying complexes ofPMEA[8"24] and a mechanism of action has
been proposed recently [25’261 in which the correct location of two metal ions at the triphosphate
chain for achieving a desired reaction is emphasized. [26] In other words, the correct orientation of
the nucleoside 5’-triphosphate or its analogue in the active-site cavity of the enzyme is crucial. [26]
One of the ways in which the correct anchoring process of a substrate in the active site of an
t’z7] enzyme can be achieved, is via stacking interactions of the nucleobase residue, e.g. with an
indole moiety of a tryptophan unit. [28] For this reason we became interested in the PMEA relatives,
9-[2-(phosphonomethoxy)ethyl]-8-azaadenine (9,8aPMEA) and 8-[2-(phosphonomethoxy)ethyl]-8-
azaadenine (8,8aPMEA) (see Fig. 1), and the question was: Do the stacking properties of PMEA,
9,8aPMEA and 8,8aPMEA differ? To this end we measured the stabilities of the mixed iigand
Cu(Arm)(PA) complexes where Arm 2,2’-bipyridine (Bpy) or 1,10-phenanthroline (Phen) and
2 2 PA- 9,8aPMEA- or 8,8aPMEA2-. These Cu(Arm)(PA) complexes can fold such that the
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aromatic rings of Bpy or Phen can interact with the 8-azaadenine residues. In fact, Bpy and Phen
have proven very helpful as indicators for evaluating the stacking capabilities of aromatic residues
in metal ion complexes. [21 A stacking interaction of the indicated kind should be reflected in an
enhanced overall complex stability.p,29,l Indeed, the results obtained prove such enhanced
stabilities and these are compared now with those obtained earlierpI for the corresponding
Cu(Arm)(PMEA) complexes.
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-O -O 3
o /CH2 o /CH2 -0
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Figure 1. Chemical structures of the dianions of 9-[2-(p.hosphonomethoxy)ethyl]adenine (PMEA2-),
9-[2-(phosphonomethoxy)ethyl]-8-azaadenine (9,8aPMEA-) and 8-[2-(phosphonomethoxy)ethyl]-8-
azaadenine (8,8aPMEA2-). The three nucleotide analogues are also abbreviated as PA2-.
2. MATERIALS AND METHODS
2.1. Materials
Twofold protonated 9-[2-(phosphonomethoxy)ethyl]-8-azaadenine, i.e. H2(9,8aPMEA), and its 8-
isomer 8-[2-(phosphonomethoxy)ethyl]-8-azaadenine, H2(8,8aPMEA), were synthesized by alkylation of 8-
azaadenine with a synthon carrying the structural features of the required side chain. [32] 2,2’-Bipyridine, 1,10-
phenanthroline monohydrate, and the nitrate salts of Na+ and Cu2+ (all pro analvsi) were from Merck AG,
Darmstadt, FRG. All the other reagents were identical with those used previouslypal and all solutions for the
potentiometric pH titrations were prepared with ultrapure CO2-free water as described,phi
2.2. PotentiometricpH Titrations
The apparatus for the potentiometric pH titrations, the calibration procedure, the computers, and the
calculatio_n methods used now are the_same as in [24]. The stability constants hmt(H.9 8aP4ZA) and Kt(9 8aP4ZA),
where Me+ Cu.(Bpy)
2+ or Cu(Phen)2+, were determined by tit_rating 30 m_L of aq6ous 0.83 mM [:tO3, 0.4
2+ 2+ mM 9,8aPMEA -, and 4.4 mM or 2.2 mM Cu /Arm (i.e., Cu :Arm:PA 11:11:1 or 5.5:5.5:1) under N2
(25 C; I 0.1 M, NaNO3) with mL 0.03 M NaOH. Each titration was repeated in the absence of ligand and
the differences in NaOH consumption between such a pair of titrations were used for the calculations.
The conditions for the measurements with 8,8aPMEA were identical with those given above for
9,8aPMEA. It may be added that the acidity constants K2(PA) and KtIH(PA for H2(PA) and H(PA)-,
tl tl + respectively, and the stability constants /Cu(H.PA, and/Cu,PAfor the binary Cu(H;PA) and Cu(PA) ....... I331 complexes were determined under the corresponding conditions. Furthermore, the above conditions are
similar to those described in [24].
Under the given experimental conditions the formation of the Cu(Arm)
2+ complexes is+ practically
complete[341 (in agreement herewith, titrations of solutions with HNO3 and HNO3 plus Cu /Arm were
identical in the lower pH range) and therefore, the evaluation of the titration data of the ternary complexes
could be done in the way described previously for binary complexes. [241 The Cu(Bpy)+/9,8aPMEA 5.5:1 and
11:1 systems were evaluated in the pH range 3.4-5.3, reaching formation degrees of about 4.5 and 8% for
Cu(Bpy)(H;9,SaPMEA)+ and 64 or 78% for Cu(Bpy)(9,SaPMEA), respectively. For the
Cu(Phen)Z+/9,SaPMEA 5.5:1 and l:l systems data were collected in the pH ranges 3.4-5.0 and 3.4-4.8,
respectively, reaching formation degrees of about 8 and 14% for Cu(Phen)(H;9,SaPMEA)
+ and about 61 or
66% for Cu(Phen)(9,SaPMEA). The upper limits of the evaluated pH ranges were always determined by the
beginning of the hydrolysis of the Cu(Arm)a species. Similarly, the Cu(Bpy)2+/8,SaPMEA 5.5:1 and 11:1
systems were evaluated between p+H 3.6-5.3 and 3.5-5.3, respectively, with formation degrees of about 7 and
12% for _Cu(Bpy)(H;8,SaPMEA) and about 62 or 76% for Cu(Bpy)(8,SaPMEA), respectively. For the
Cu(Phen)e+/8,SaPMEA 5.5:1 and l:l systems data were collected in the pH ranges 3.6-5.0 and 3.5-5.0,
respectively, reaching formation degrees of about 12 and 19% for Cu(Phen)(H;8,SaPMEA)
+ and 60 or 73%
for Cu(Phen)(8,SaPMEA), respectively.
The calculated stability constants showed no dependence on pH or on the excess of Cu-+/Arm
employed. The final results for the constants are in each case the averages of the evaluations of five
independent pairs of titrations. However, due to the low formation degrees reached for the monoprotonated
M(H;PA)
+/- species, the stability constants given for these complexes must be considered as estimates. These
estimates were further substantiated by comparisons with the known[181 values of the Cu(Arm)(H;PMEA)
+
H complexes by taking the different acidity constants (Kz(pA)) into account.
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2.3. Spectrophotometric Measurements
The UV-Vis spectra of the Cu2+/Phen/9,8aPMEA or 8,8aPMEA systems were recorded in aqueous
solution and 1-cm cells with a Varian Cary 3C spectrophotometer connected to an IBM-compatible desk
computer (OS/2 system) and an EPSON stylus 1500 printer. The pH of the solutions was adjusted by dotting
with relatively concentrated NaOH and measured with a Metrohm 713 pH meter using a Metrohm 6.204.100
glass electrode. Further details are given in the legend of Figure 4 in Section 3.5.
3. RESULTS AND DISCUSSION
All potentiometric pH titrations (25 C; I 0.1 M, NaNO), the results of which are summa-
rized below, were carried out with a ligand concentration of 0.4 mM and at CuZ+/Arm concentra-
tions equal to or below 4.4 mM. Under these conditions self-stacking of the ligands is negligibly
small as has been shown[81 for PMEA; the same applies to the self-association of Cu(Phen)r+.[3]
This means, the self-association is negligible for any of the reactants under the present experimen-
tal conditions and the results given below certainly refer to monomeric species.
3.1. Definition ofthe Equilibrium Constants
The ligands 9,8aPMEA2- and 8,8aPMEA2-, abbreviated as PA2- (Fig. 1), may bind two
protons at the phosphonate group and one at N1 of the adenine moiety. From H(PMEA)
+ the first
proton is released from the -P(O)(OH)2 residue[] with pKa 1.2 and the same may be surmised
for the other H(PA)+ species. Hence, for the present work only the release of the proton from the
+ (N1)H site, followed by the one from the -P(O)z(OH)- group need to be considered:
H2(PA)
+/- H(PA)- + H+ (la)
/H2(PA) [H(PA)-] [H+]/[H2(PA)+] (1 b)
H(PA)- PA2- + H+ (2a)
/H(PA) PA2-] [H+]/[H(PA)-] (2b)
Indeed, the experimental data of the potentiometric pH titrations of the M2+/pA systems, where
M2+ Cu2+, Cu(Bpy)2+ or Cu(Phen)2+, can be fully described by considering the acidity constants
of Ha(PA)
+/- (eqs (1) and (2)) and the following equilibria (3) and (4),
M2+ + H(PA)- , M(H;PA)+ (3a)
KM(H;PA) [M(H;PA)+]/([M2+] [H(PA)-]) (3b)
M2+ + PA2- : M(PA) (4a)
/(PA) [M(PA)]/([M2+] [pA2-]) (4b)
provided the evaluation of the data is restricted to the pH range below the beginning of the forma-
tion of hydroxo complexes which was evident from the titrations ofM2+ without ligand. It should
be noted that in formulas like M(H;PA)+ the H+ and the PA2- are separated by a semicolon to
facilitate reading, yet they appear within the same parentheses to indicate that the proton is at the
ligand without defining its location.
Equilibria (3a) and (4a) are connected via equilibrium (5a), and the corresponding acidity
constant (eq. (5b)) may be calculated with equation (6):
M(H;PA)+ M(PA) + H+
]-IM(H;PA [M(PA)] [H+]/[M(H;PA)+1
(5a)
(5b)
P/M(H;PA) P/H(PA) + log KMMM(H;PA)- log KMMM(PA) (6)
The equilibrium constants according to equations (3), (4), and (5) are listed in columns 2, 3, and 4
of Table 1, respectively. The acidity constants of the ligands (see footnote "a" in Table 1) and the
stability constants of the binary Cu(H;PA)+ and Cu(PA) complexes will be discussed in a different
context. [33] Here we concentrate on the properties of the ternary complexes.
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Table 1. Logarithms of the Stability Constants of the Ternary Cu(Arm)(H;PA)
+ (eq. (3)) and Cu(Arm)(PA)
(eq. (4)) Complexes as Determined by Potentiometric pH Titrations in Aqueous Solution, Together with the
Negative Logarithms of the Acidity Constants (eqs (5) and (6)) of the Cu(Arm)(H;PA)
+ Species at 25 C
and I 0.1 M (NaNO3)a’b
M /M(PA) M(PA) log KM(H;PA log P/(H;PA) A log KCu/Arm/PA
d
Cu(9,8aPMEA)[33] 0.95+ 0.25 3.98 + 0.04 3.8 + 0.25
Cu(Bpy)(9,8aPMEA) 1.4 + 0.25 4.56 + 0.06 3.7 + 0.3 0.58 + 0.07
Cu(Phen)(9,8aPMEA) 1.7 + 0.25 4.81 + 0.06 3.7 + 0.3 0.83 + 0.07
Cu(8,8aPMEA)[33] 1.3 + 0.25 3.68 + 0.06 4.4 + 0.25
Cu(Bpy)(8,8aPMEA) 1.7 + 0.25 4.49 + 0.05 4.0 + 0.3 0.81 + 0.08
Cu(Phen)(8,SaPMEA) 2.0 + 0.25 4.79 + 0.07 4.0 + 0.3 1.11 + 0.09
a The acidity constants ofH2(9,8aPMEA)
+/- are pgHH2t9 8aPMEA 2.73 + 0.02 and pKHH(9,8aPWWA 6.85 + 0.02;
those ofH2(8,8aPMEA)
+ are pKHH2(8 8aPMEA)-" 3.56’4’ 0.02 ahd pKHH(8 8aPMEA)- 6.79 + 0.Ol. 3"3],b
b The errors given are three times’the standard error of the me.n value or the sum of the probable
systematic errors, whichever is larger. The error limits of the derived data (columns 4 and 5) were
calculated according to the error propagation after Gauss.
The values in this column are estimates (see Section 2.2)
d Stability constant differences calculated according to eq.’(9).
3.2. On the Structure ofthe Monoprotonated Ternary Cu(Arm)(H;PA)+ Complexes
The analysis of potentiometric pH titrations only yields the amount and distribution of the
species of a net charged type; i.e., further information is required to locate the binding sites of the
proton and the metal ion in Cu(Arm)(H;PA)+ species. A comparison of the acidity constants of
H2(9,8aPMEA)+, P/H2(9,8aPMEA) 2.73 an.d P/H(9,8aPMEA)= 6.85, with pKCu(Arm)(H;9,8aPMEA) 3.7
(Table 1) of the Cu(Arm)(H;9,8aPMEA)* complexes reveals that the proton in these complexes
must be located at the phosphonate group, since metal ion coordination must give rise to an
acidification, [36,371 which amounts to A pKa pKIH(9,8aPMEA)- pKCu(Arm)(H;9,8a+PMEA) (6.85 4- 0.02)
--(3.7 + 0.3) 3.15 + 0.3 in the present case. In the Cu(Arm)(H;8,SaPMEA) species the proton is
also clearly bound at the phosphonate group though the acidification due to the metal ion might be
somewhat less pronounced: A pKa PH(8,SaPMEA)- P/Cu(Arm)(H;8,8aPMEA) (6.79 +/- 0.01) (4.0 +-
0.3)=2.8+0.3.
Where is the Cu(Arm)2+ unit located? In principle, there are two possibilities" One, where
Cu(Arm)
2/ is stacked with the purine system of H(PA)-, designated as [Cu(Arm)/(H;PA)]s, and
another one, where Cu(Arm)2+ is coordinated either to the N1/N7 sites of the adenine residue (see
[24]), [H;PA’Cu(Arm)]a+de, or to the phosphonate group which already_ carries the proton. However,
the formation of this latter species with both the proton and Cu(Arm)+ at the phosphonate group is
unlikely, in agreement with previous conclusions. [241 Hence, we are left with the species
[H;PA’Cu(Arm)]a+de and [Cu(Arm)/(H’PA)] +, st and we have to consider the intramolecular
equilibrium (7):
[H;PA.Cu(Arm)]a+de [Cu(Arm)/(H;PA)]s (7)
An evaluation following exactly the route described in [2] leads to the conclusion that for all four
Cu(Arm)(H;PA)+ systems the stacked species in equilibrium (7) dominate with formation degrees
of more than 70%, most likely being between 80 and 95%. As one might expect, the formation
degree of [Cu(Phen)/(H;PA)]s is about 10% larger than the one of [Cu(Bpy)/(H;PA)]s.
3.3. Proofofan Increased Stability ofthe MixedLigand Cu(Arm)(PA) Complexes
[38391 The stability of mixed-ligand complexes may be quantified by considering equilibrium
(8a); the corresponding equilibrium constant is calculated with equation (9).
Cu(Arm)2+ + Cu(PA) .... Cu(Arm)(PA) + Cu2+
10zx log KCu/Arm/PA [Cu(Arm)(PA)] [Cu2+]
[Cu(Arm)
2+ [Cu(PA)]
(8a)
(8b)
A2u(Arm) --log/C(PA) A log KCu/Arm/PA log "Cu(Arm)(PA) (9)
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According to the general rule for complex stabilities, K > K?, equilibrium (8a) is expected to be on
the left side with negative values for A log KCu/Arm/PA, in agreement with statistical conside-
rations, [38’39] i.e., A log Kcu/statist -0.5. [39] From te values listed in column 5 of Table it is
evident that equilibrium (8) is significantly displaced to the right side. More important, however, is
a comparison with the results obtained for the dianion of phosphonomethoxyethane (PME:-),
CH3CH2-O.CH2-PO-, which reflects the properties of the side chain of9,8aPMEA 2- and
8,8aPMEA’-- (Fig. 1). Indeed, these results, A log KCu/Bt)v/PME 0.13 + 0.04 and A log Kcu/Phen/PME
0.17 + 0.05,[311are considerably smaller than the valuers ofA log KCu/Arm/PA for the Cu(Arm)(PA)
complexes, which means that the adenine residue contributes to the stability of the Cu(Arm)(PA)
species. This comparison thus provides the first clear hint for the occurrence of an intramolecular
stacking interaction in these latter mentioned complexes.
Another way to evaluate the increased stability of ternary Cu+ complexes, independently of
the properties of the binary Cu(9,8aPMEA) and Cu(8,8aPMEA) species, rests on the previously
established[2’311 straight-line correlations for log KUu(rrmm) RPO versus p/ po) plots (eqs (10) c )( 3)
and (11)), where R-PO- represents phosphate monoester or phosphonate lgands in which the
residue R is unable to interact with Cu(Arm)Z/:
log Kou(Bpy) 0.465 x Cu(Bpy)(R-PO3) P/H(R-PO3) + 0.009 (10)
log zCu(Phen)
"’Cu(Phen)(R-PO3) 0.465 x PKH(R.PO3 + 0.018 (11)
The error limits of log stability constants calculated with given p/,, values and equations H(R-PO3
(10) and (1 1) are +0.07 and +0.06 (3) log units, respectively, in the pH range 5-8.[311
The reference lines as defined by equations (10) and (11) are shown in Figure 2, where the
stability constants log Kou(Arm) versus the acidity constants pK of the 9,8aPMEA and Cu( m)(P
8,8aPMEA species are also pAlrotte, together with the corresponding dat’al] of the Cu(Arm)(PME)
systems. All these data points are above their reference lines, proving an increased complex
stability which must mean[41 that aside from 2+ the Cu(Arm) -phosphonate coordination further
interactions take place. The vertical distances in Figure 2 between the data points due to
Cu(Arm)(9,8aPMEA), Cu(Arm)(8,8aPMEA) and Cu(Arm)(PME) and the reference lines are a
measure for the extent of the intramolecular interactions in these complexes and they can be
defined according to equation (12) (in this case, PA2- also represents PME2-)
log ACu/Arm/PA log r,.’Cu(Arm) log r,.’Cu(Arm)
’Cu(Arm)(PA) a"Cu(Arm)(PA)op (12a)
k,-Cu(Arm) log k,Cu(Arm) log ’"Cu(Arm)(PA)exptl "Cu(Arm)(PA)calcd (12b)
u(Arm) u(Arm) The expressions log (eq (12b)) and log Kcu Arm PA o (eq (12a)) are synonymous /u(Arm)(PA)calcd p
because the calculated value equals the stability constant of the lopen’ isomer, Cu(Arm)(PA)o,, n
2 2+ which only a -PO3-/Cu(Arm) interaction occurs. The first term on the right hand side in equation
(12) is the experimentally determined stability constant (eft. (4)), whereas a value for log
K(2t/!. Arm), can be calculated with the acidity constant P/’"PA’ and the straight-line equations
(1--0utV(l]ai"As indicated above, such a calculated value har{tifies the stability of the open
isomer.
The ligand PME2- offers to metal ions the phosphonate group for coordination, but an inter-
action with the ether oxygen is also possible as has repeatedly been proven. [822’41’421 This gives
rise to 5-membered chelates and therefore equilibrium (13a) needs to be considered"
H O
ROCP,0,,
%"M2+ R-- 0,,,,
H 0 %M2"
(13a)
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K [Cu(Arm)(PME)c]/[Cu(Arm)(PME)op] (13b)
The dimensionless equilibrium constantK (eq. (13b)) is calculated according to equation (14),
K 10lg aCu/Arm/PME (14)
5,0-
4,8-
4.6-
’E 4.4-
tOO 4.2
4.0-
3.8
3.6
O 3.4
E
z m 2.8
2.6
2.4-
2.2
8,8aPMEA2-
O09,8aPMEA2"
, PME2-
"’,Cu(Bpy)(R.PO3)
(Phen)(R-PO3)
6.0 6.2 6.4 6.6 6.8 7.0 7.2 7.4 7.6 7.8 8.0 8.2
H pKHH(R.PO3) or PKH(PA
Figure 2. Evidence for an enhanced stability of the ternary Cu(Arm)(9,8aPMEA)
Cu(Arm)(8,SaPMEA) ((C),O), and Cu(Arm)(PME) (A,,) complexes based on the relationship between log
/,,_u(Ann
u(Ann)(r-PO3) or log "Cu(Ann)(PA)and PK(R-PO3) or pKIH(pA) in aqueous solution at I 0.1 M (NaNO3) and
25 C. The plotted data for 9,8aPMEA and 8,8aPMEA are from Table and those for PME from [31]. The
ASu(Ann) two reference lines represent the log Cu(Ann)(r.po3)versus P/(-PO3) relationship for ternary
Cu(Arm)(R-PO3) complexes (eqs (10) and (11)); R-PO- symbolizes phosphonates or phosphate monoesters
in which the group R is unable to undergo any kind of hydrophobic, stacking or other type of interactions, i.e.
ligands like D-ribose 5-monophosphate, methanephosphonate or ethanephosphonate. [31 The broken line holds
for Arm Bpy and the solid line for Arm Phen. Both straight lines represent the situation for ternary
complexes without an intramolecular ligand-ligand interaction. The vertical dotted lines emphasize the
stability differences from the reference lines; they equal log ACu/Arm/PA as defined in equation (12).
and now, knowing K, the percentage of the closed isomer, Cu(Arm)(PME)c, in equilibrium (13a)
can be obtained with equation (15)"
% Cu(Arm)(PME)c 100. K/(I + KI) (15)
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Table 2. Quantification of the Stability Increase via loe ZCu/Arm/PA (eq. (12)) for the Cu(Arm)(PA)
Complexes, where PA 9,8aPMEA2-, 8,8aPMEA2- or PME"-, and Arm Bpy or Phen, Together with the
Extent of the Intramolecular Chelate Formation (eq. (13)) in the Cu(Arm)(PME) Species[311 in Aqueous
Solution at 25 C and I 0.1 M (NaNO3)
a
log 1o
Cu(Arm)(PA)
vCu(Ann) b vCu(Ann Kia Cu(Ann)(PA)exptl Cu(Ann)(PA)calcd log ACu/Ann/PA %Cu(Arm)(PME)cl
Cu(Bpy)(9,8aPMEA) 4.56 + 0.06
Cu(Phen)(9,8aPMEA) 4.81 + 0.06
3.19 + 0.07 1.37 + 0.09
3.20 + 0.06 1.61 + 0.08
Cu(Bpy)(8,8aPMEA) 4.49 + 0.05 3.17 + 0.07 1.32 + 0.09
Cu(Phen)(8,8aPMEA) 4.79 + 0.07 3.18 + 0.06 1.61 + 0.09
Cu(Bpy)(PME)[31] 3.86 + 0.03 3.27 + 0.07 0.59 + 0.08 2.89 + 0.68 74 + 5
Cu(Phen)(PME)tr31] 3.90 + 0.04 3.28 + 0.06 0.62 + 0.07 3.17 + 0.69 76 + 4
For the error limits see footnote ’b’ ofTable 1.
These values are from column 3 in Table 1.
These constants were calculated with eqs (10)or (11) and the H pK(pA values given in footnote ’a’ of Table 1.
See eqs (13b) and (14).
Calculated according to equation (15).
From the results given in the lower part of Table 2 it is evident that the closed isomer of
Cu(Arm)(PME) is an important species with a formation degree of about 75%. Naturally, the for-
mation of the corresponding isomer involving the ether oxygen is also to be expected (see Fig. 1)
for the Cu(Arm)(9,8aPMEA) and for Cu(Arm)(8,8aPMEA) systems and we designate it as
Cu(Arm)(PA)vo. However, the log ACu/Arm/PA values listed in column 4 of Table 2 are by about 0.7
to log unit larger for the latter mentioned complexes than for the Cu(Arm)(PME) species and this
must mean that in the systems with 9,8aPMEA and 8,8aPMEA, next to Cu(Arm)(PA)op and
Cu(Arm)(PA)l/o, a third isomer must occur which involves the adenine residue. The ligands
9,8aPMEAz- and 8,8aPMEA2- offer only two such possibilities" The phosphonate-coordinated
Cu(Arm)2+ forms (i) a macrochelate with one of the nitrogens of the adenine residue, or (ii) an
intramolecular stack between the aromatic ring systems of Bpy/Phen and the adenine moiety. That
the first possibility is not of relevance has been discussed in detail for 3’-deoxa-PMEA, [21 and the
same arguments also apply here, whereas for the second possibility involving intramolecular
stacks, many examples exist. [2,28,30,31,39’40’43] Hence, the additional enhanced complex stability may
be attributed indeed to intramolecular stack formation.
Application of space-filling molecular models reveals that the adenine residue of the
9,8aPMEA or 8,8aPMEA ligands, which are equatorially chelated to Cu(Arm)2+ via the phospho-
hate group and the ether oxygen, cannot stack well with the aromatic rings of the also equatorially
coordinated Arm; a substantial and strain-free overlap of the aromatic systems is only possible if
the ether oxygen is not equatorially coordinated to Cue+. This latter situation is depicted in Figure 3
for 9,8aPMEA. However, from the molecular models it is also evident that an apical ether oxygen
coordination and simultaneous stack formation would be compatible with each other in the
Cu(Arm)(PA) species with PA2- 9,8aPMEA or 8,8aPMEA. Hence, there are various intramole-
cularly stacked Cu(Arm)(PA) species possible including those with somewhat different orientations
of the aromatic rings toward each other. As there is at present no way to distinguish these various
isomers and conformers from each other, we treat all the stacked species together and designate
them as Cu(Arm)(PA)st. The sum of the above reasonings then gives rise to the equilibrium scheme
(16), where the pure phosphonate-coordinated isomer is designated as Cu(Arm)(PA)op. It is evident
that the upper branch of this equilibrium scheme reflects equilibrium (13a) while the lower branch
reflects the stacking interaction (Fig. 3).
Cu(Arm)(PA)c,o
Cu(Arm)
2+ + PA
2- Cu(Arm)(PA)op
Cu(Arm)(PA).t
(16)
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H2NV7x
/,OH ’
H2!
O
Figure 3. Tentative and simplified structure of a Cu(Phen)(9,8aPMEA) species with an intramolecular stack.
The orientation of the aromatic rings may vary among the stacked species; such a stacked complex in
solution should not be considered as being rigid.
3.4. Evaluation ofthe Intramolecular Equilibria Involving Three Different Cu(Arm)(PA)
Species
Based on the equilibrium scheme (16) the corresponding equilibrium constants can be
defined as given in equations (17)-(19):
log "R2u(Arm)(PA)opk’Cu(Arm) [Cu(Arm)(PA)op]/([Cu(Arm)2+] [pA2-]) (17)
KI/o [Cu(Arm)(PA)cl/O]/[Cu(Arm)(PA)op] (18)
Kl/st [Cu(Arm)(PA)st]/[Cu(Arm)(PA)op] (19)
With these definitions the experimentally accessible equilibrium constant (4b) can be reformulated
as equation (20): [20a,31]
[Cu(Arm)(PA)] (4b) (Arm)(PA) [Cu(Arm)2+ [pA2_]
([Cu(Arm)(PA)op] + [Cu(Arm)(PA)cl/O] + [Cu(Arm)(PA)st ])
[Cu(Arm)
2+ [PA
2-
/(Cu(Arm) k-Cu(Arm) + Kl/st" "’Cu(Arm)(PA)op
k,Cu(Arm) + KI/O "’Cu(Arm)(PA)op "xCu(Arm)(PA)op
(20a)
(20b)
k’Cu(Arm)
"’Cu(Arm)(PA)op (1 + KI/0 + Kl/st) (20c)
From here one arrives easily[31 at equation (21), where Cu(Arm)(PA)int/tot refers to the sum of all
the species with an intramolecular interaction:
Cu(Arm)
Cu(Arm)(PA) 10Ig ACu/Arm/PA (21 a) K Kl/to ,Cu(grm)
"’Cu(Arm)(PA)op
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[Cu(Arm)(PA)int/tt (21 b) /’(i Kl/tot [Cu(Arm)(PA)op
[Cu(Arm)(PA)cl/O] + [Cu(Arm)(PA)st]
[Cu(Arm)(PA)op
(21c)
KI/0 + Ki/st (2 d)
In those instances where the stacked species do not form, the above equations reduce to the two-
isomer problem treated in equations (13) and (14). It is evident that/I Kl/tot according to equa-
tion (21a) can be calculated via the values log ACu/Arm/PA as defined by equation (12) and listed in
the upper part of column 4 in Table 2.
Table 3. lntramolecular Equilibrium Constants for the Formation of the Three Differently Structured
Cu(Arm)(PA) Species Shown in the Equilibrium Scheme (16), Together with the Percentages in Which
These Species Occur in Aqueous Solution at 25 C and I 0.1 M (NaNO3)
a
No. Cu(Arm)(PA) log ACu/Ann/l:,A g’= KI/tot %Cu(Arm)(PA)int/tot %Cu(Arm)(PA)op
a Cu(Bpy)(9,8aPMEA)
2a Cu(Phen)(9,8aPMEA)
1.37 + 0.09 22.44 + 4.86 95.73 + 0.88 4.27 + 0.88
1.61 + 0.08 39.74 + 7.50 97.55 +/- 0.45 2.45 + 0.45
3a Cu(Bpy)(8,8aPMEA) 1.32 + 0.09 19.89 + 4.33
4a Cu(Phen)(8tSaPMEA) 1.61 + 0.09 39.74 + 8.44
No. Cu(Arm)(PA) K I/O Ki/st
95.21 + 0.99 4.79 + 0.99
97.55 + 0.51 2.45 +/- 0.51
%Cu(Arm)(PA)el/o
b %Cu(Arm)(PA)st
b Cu(Bpy)(9,SaPMEA) 2.89 +/- 0.68 19.55 + 4.91
2b Cu(Phen)(9,SaPMEA) 3.17 +/- 0.69 36.57 +/- 7.53
3b Cu(Bpy)(8,SaPMEA) 2.89 +/- 0.68 17.00 +/- 4.38
4b Cu(Phen)(8,8aPMEA) 3.17 + 0.69 36.57 +/- 8.47
12.3 +/- 3.9 83.4 +/- 4.0
7.8 +/- 2.2 89.8 +/- 2.2
13.8 +/- 4.3 81.4 +/- 4.4
7.8 + 2.3 89.8 + 2.4
a The values listed in the third column of the upper part are from the fourth column in the upper part of Table
2. The values for K’ Ki/tot follow from eq. (21a) and %Cu(Arm)(PA)int/tot is calculated analogously to eq.
(15). The values given in the sixth column for %Cu(Arm)(PA)op follow from 100 %Cu(Arm)(PA)int/tot.
The constants for Kvo in column 3 of the lower part are from column 5 in the lower part of Table 2 (for the
corresponding justification[311 see also text in Section 3.4); with eq. (21d) and the now known values for K’
and KI/0 that for Kl/st may be calculated (column 4 in the lower part). All error limits correspond to three
times the standard deviation (3); they were calculated according to the error propagation after Gauss.
b These values were calculated via eq. (18) with Kvo and %Cu(Arm)(PA)op.
The values for %Cu(Arm)(PA)st follow from the difference %Cu(Arm)(PA)int/tot- %Cu(Arm)(PA)cl/o (cf.
eqs (21b) and (2 c)); %Cu(Arm)(PA)st may also be calculated via eq. (19) with Kvst and %Cu(Arm)(PA)op.
The results are the same for both calculation methods yet the error limits are understandably larger for the
second method (data not shown).
The resultingK values are given in the fourth column of the upper part of Table 3 and they allow
to calculate the concentrations of the open isomers, Cu(Arm)(PA)op. To be able to calculate the
formation degree of the species that form the five-membered chelate with the ether oxygen, i.e.
Cu(Arm)(PA)c/O (eq. (18)), we made the justified assumption that Cu(Arm)(PME)c (Section 3.3;
Table 2)I31 and Cu(Arrn)(PA)cl/O have the same stability, i.e. that the equilibrium constant Kvo for
Cu(Arm)(PA)cVO equals the corresponding value (= K) for Cu(Arm)(PME)c. Knowledge ofK
and K/o permits now to calculate K/st by using equation (21d) and hence the formation degree of
the Cu(Arm)(PA)st species. Finally, the difference between 100 and the sum of the percentages for
Cu(Arm)(PA)op and Cu(Arrn)(PA)cvO will, of course, also result in % Cu(Arm)(PA)st and Ki/st. The
results of theseCalculations are summarized in the lower part of Table 3.
Considering the equilibrium scheme (16) and the corresponding results summarized in Table
3 several conclusions are evident: (i) All three structurally different species are formed in
appreciable amounts in the Cu(Phen)(9,8aPMEA) and Cu(Phen)(8,SaPMEA) systems. (ii) The
stacked species (Fig. 3) clearly dominate, reaching formation degrees of about 80 to 90%. (iii)
Consequently, the formation degree of the five-rnembered chelates involving the ether oxygen is
suppressed, roughly speaking to about 10%, compared with the approximately 75% present in the
Cu(Arrn)(PME) systems (cf Table 2).
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A further aspect that warrants emphasis is the fact that the values for Ki/st are lower by a
factor of about one half for the complexes containing Bpy compared with those containing Phen
(Table 3, column 4 in the lower part). The corresponding observation has previously been made in
studies with adenosine 5’-monophosphate (AMp2-)H] and other adenine derivatives.[ ] Evidently
this is the result of the smaller aromatic-ring system of 2,2’-bipyridine, compared to that of 1,10-
phenanthroline, which gives rise to a less pronounced overlap with the adenine residue.
3.5. Spectrophotometric Confirmation ofStacking in the Cu(Phen)(PA) Systems
The results of Section 3.4 provide very clear though indirect evidence, obtained via stability
constant comparisons, for stack formation in the ternary complexes. Direct evidence for the forma-
tion of the stacks can be obtained via either H NMR shift experiments[28’4] or spectrophotometric
measurements. [28,,46,471 The first-mentioned method is excluded because of the line broadening
effects of Cu2+. However, the second method, which is based on the experience that the formation
of stacked adducts is connected with the observation of charge-transfer bands, [28’’46’47] should be
suitable.
Indeed, the spectrophotometric measurements carried out for the Cu(Phen)(9,SaPMEA) and
Cu(Phen)(8,SaPMEA) systems, which are summarized in Figure 4, confirm the formation of stacks
in the ternary species. The difference spectra reveal the occurrence of new absorption bands at
approximately_ 335 and 350 nm in accordance with previous observations of various Cu(Bpy)2+ [46]
and Cu(Phen)2+ [47] systems with nucleotides,p’48]
The spectrophotometric measurements seen in Figure 4 are not very precise. It was difficult
to adjust a pH of 4.5 in the solutions without obtaining a precipitation of hydroxo complexes and
the values of the difference-absorptions (AA) measured are very small. Therefore, a quantitative
evaluation of these data is not appropriate; important for the present context is the simple fact that
the data confirm stacking.
0.14
0.12
0.10
0.08
0.06
0.04
.0.02
0.00
0.08
0.06
0.04
0.02
0.00
330 340 350 360 370 380 390 400
Wavelength,nm
Figure 4. Difference absorption spectra for the ternary Cu2+/Phen/9,8aPMEA (lower part) and
Cu2+/Phen/8,8aPMEA (upper part) systems measured in 1-cm cells, i.e., the reference beam contained
one cell with CuZ+/Phen and a second one with the corresponding azaPMEA derivative; the sample beam
contained one cell with the mixed ligand system and one with water. The azaPMEA concentrations were
10-3 M and those of Cu(NO3)z/Phen were 1.32 x 10
-3 M (1), 2.64 x 10-3 M (2) and 5.28 x 10-3 M (3)
[Cu(Phen)
2+ is nearly completely formed under the given conditions]. NaNO3 was added to all four
solutions to maintain I 0.1 M. The pH was always adjusted to 4.50 + 0.02 by dotting with relatively
concentrated NaOH (at higher pH hydroxo-complex formation occurs). See also Section 2.3.
4. CONCLUSIONS
The present study reveals several interesting properties of PMEA and its derivatives: (i) It is
relatively astonishing to observe that the binding of the side chain either at N9 or at N8 (see Fig. 1)
does not affect the stacking properties in the ternary complexes studied; i.e., the extent of stacking
is within the error limits identical in Cu(Arm)(9,8aPMEA) and Cu(Arm)(8,8aPMEA) (Table 3,
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column 6 in the lower part). This means most likely that the side chain is long enough to provide
the flexibility needed for a favorable orientation of the aromatic rings in the stacks in both types of
complexes. (ii) The extent of stacking of the two azaPMEAs in their Cu(Arm)2+ complexes is
within the error limits identical with that of PMEA[] and 3’-deoxa-PMEA[21 in the corresponding
ternary complexes. This means, the deletion of the ether oxygen from the side chain as well as the
presence of an ’extra’ nitrogen atom in the adenine residue do not affect the stacking properties of
the purine system. (iii) Furthermore, even the stacking properties of the Cu(Arm)(AMP) species[441
are within the error limits identical with those of the mentioned ternary complexes. In other words,
as far as the stacking properties are concerned, all of the mentioned PMEA derivatives resemble
closely the parent nucleotide, adenosine 5’-monophosphate (AMp2-).
A further point of interest is that 9,8aPMEA shows in vitro some antiviral activity whereas
the 8,8a isomer does not. [49,5] Why? Based on the presented results one may suggest that both
nucleotide analogues could possibly bind via stacking to the active site of the enzyme in question,
but that the orientation within the active site is different preventing thus the desiredI26] biological
action.
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